期刊文献+

醛固酮受体拮抗剂螺内酯治疗持续性心房纤颤的疗效观察 被引量:1

下载PDF
导出
摘要 目的观察醛固酮受体拮抗剂螺内酯治疗持续性心房纤颤(房颤)的疗效。方法选择持续性房颤胺碘酮复律后患者40例,随机分成两组,试验组口服胺碘酮0.2g1次/d维持,对照组为胺碘酮0.2g1次/d+螺内酯40mg1次/d。随访1年,观察房颤转复窦性心律后1年房颤复发率。结果治疗后口服螺内酯组患者房颤的复发率明显少于对照组,差异有统计学意义(P<0.05)。结论螺内酯可以减少持续性房颤的复发。
出处 《临床合理用药杂志》 2012年第6期46-46,共1页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献3

  • 1Dixen U,Ravn L,Soeby-Rasmussen C,et al.Raised plasma aldosterone and na-triuretic peptides in atrial fibrillation[J].Cardiology,2007,108(1):35-39.
  • 2裴德安,李莉,徐志云,黄进宇,徐正明,王敏,姚强,黄世恩,黄琪.心房颤动患者心房组织醛固酮和心房基质重构研究[J].心脏杂志,2009,21(1):41-45. 被引量:1
  • 3Bunda S,Wang Y,Mitts TF,et al.Aldosterone stimulates elastogen-esis in cardiac fibroblasts via mineralocorticoid receptor-independ-ent action involving the consecutive activation of Galpha13,c-Src,the insulin-like growth factor-I receptor,and phosphatidylinositol3-kinase/Akt[J].Biol Chem,2009,284:16633-16647.

二级参考文献15

  • 1裴德安,李莉.心房颤动总是“引发”心房颤动吗?[J].国际心血管病杂志,2006,33(3):166-169. 被引量:3
  • 2Spach MS. Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation[ J ]. Circ Res, 2007, 101 (8) :743 -745.
  • 3Healey JS, Morillo CA, Connolly SJ. Role of the renin-angiotensinaldosterone system in atrial fibrillation and cardiac remodeling [ J ]. Cur Opin Cardiol, 2005, 20( 1 ) :31 -37.
  • 4Birnie DH, Gollob M, Healey JS. Clinical trials, the renin angiotensin system and atrial fibrillation [ J ]. Curr Opin Cardiol, 2006, 21 (4) :368 -375.
  • 5Connell JM, Davies E. The new biology of aldosterone[ J]. J Endocrinol, 2005, 186 ( 1 ) : 1 - 20.
  • 6Goette A, Haffmanns P, Enayati W, et al. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation[ J]. Am J Cardiol, 2001, 88 (8) :906 -909.
  • 7Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients [ J ]. Cardiovasc Res, 2002, 54 (2) : 361 - 379.
  • 8Everett TH 4th, Li H, Mangrum JM, et al. Electrical, morphological and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation [ J ]. Circulation, 2000, 102 (12) : 1454 - 1460.
  • 9Verheule S, Sato T, Everett T 4th, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective alrial fibrosis caused by overexpression of TGF-betal [ J ], Circ Res, 2004, 94 (11) :1458 - 1465.
  • 10Lombes M, Alfaidy N, Eugene E, et al. Prerequisite for aldosterone action: mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase in the human heart[J]. Circulation, 1995,92(2) :175 -182.

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部